Chao Feng Hao
Director of Finance/CFO chez Jiangsu Cowin Biotech Co., Ltd.
Fortune : 24 739 $ au 31/03/2024
Profil
Chao Feng Hao is currently the Finance Director & Deputy General Manager at Jiangsu Cowin Biotech Co., Ltd.
Prior to this, he worked as the Chief Financial Officer at Shanghai Shyndec Pharmaceutical Co., Ltd.
and WPG (Shanghai) Smart Water Public Co., Ltd.
Mr. Hao completed his undergraduate degree at Zhengzhou Institute of Aeronautical Industry Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/04/2023 | 20 000 ( 0,00% ) | 24 739 $ | 31/03/2024 |
Postes actifs de Chao Feng Hao
| Sociétés | Poste | Début |
|---|---|---|
Jiangsu Cowin Biotech Co., Ltd.
 Jiangsu Cowin Biotech Co., Ltd. BiotechnologyHealth Technology Jiangsu Cowin Biotech Co., Ltd. engages in the provision of molecular testing services as well as the research and development of molecular testing products. Its products include raw materials for molecular detection enzymes, nucleic acid preservation reagents, nucleic acid extraction and purification reagents, and molecular diagnostic kits. The company was founded by Chun Xiang Wang on September 3, 2010 and is headquartered in Taizhou, China. | Director of Finance/CFO | 27/10/2023 |
Anciens postes connus de Chao Feng Hao
| Sociétés | Poste | Fin |
|---|---|---|
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Director of Finance/CFO | 16/06/2023 |
| WPG (SHANGHAI) SMART WATER PUBLIC CO.,LTD. | Director of Finance/CFO | - |
Formation de Chao Feng Hao
| Zhengzhou Institute of Aeronautical Industry Management | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Health Technology |
| WPG (SHANGHAI) SMART WATER PUBLIC CO.,LTD. | Producer Manufacturing |
 | Health Technology |
